| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Fibroblast growth factor receptor 1 (FGFR1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY414376 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 1 (FGFR1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY411517 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog) (FGF3) from ORIGENE TECHNOLOGIES | LY417426 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 1 (FGFR1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429471 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 1 (FGFR1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY429717 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 1 (FGFR1), transcript variant 5 from ORIGENE TECHNOLOGIES | LY411518 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 1 (FGFR1), transcript variant 5 from ORIGENE TECHNOLOGIES | LY429718 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 1 (FGFR1), transcript variant 6 from ORIGENE TECHNOLOGIES | LY429719 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 2 (FGFR2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400050 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 2 (FGFR2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY402962 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 1 (FGFR1), transcript variant 6 from ORIGENE TECHNOLOGIES | LY411519 | 100 ug | ORIGENE TECHNOLOGIES |
| Fibroblast growth factor receptor 3 (FGFR3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424902 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 49 (C7orf49), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411410 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 46 (C7orf46), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426759 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 50 (C7orf50), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427414 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 50 (C7orf50), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410187 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 50 (C7orf50), transcript variant 3 from ORIGENE TECHNOLOGIES | LY427415 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 53 (C7orf53), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403647 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 58 (C7orf58), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411011 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 53 (C7orf53), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427449 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 63 (C7orf63), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431643 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 7 open reading frame 68 (C7orf68), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420675 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 34 (C8orf34), transcript variant 2 from ORIGENE TECHNOLOGIES | LY434191 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 40 (C8orf40), transcript variant 3 from ORIGENE TECHNOLOGIES | LY408691 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 41 (C8orf41), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426172 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 41 (C8orf41), transcript variant 2 from ORIGENE TECHNOLOGIES | LY410894 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 47 (C8orf47), transcript variant 1 from ORIGENE TECHNOLOGIES | LY406460 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 58 (C8orf58), transcript variant 2 from ORIGENE TECHNOLOGIES | LY434181 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 58 (C8orf58), transcript variant 3 from ORIGENE TECHNOLOGIES | LY434144 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 41 (C8orf41), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420143 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 79 (C8orf79), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412265 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 59 (C8orf59), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420485 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 79 (C8orf79), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420489 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 83 (C8orf83), transcript variant 4 from ORIGENE TECHNOLOGIES | LY432514 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 9 open reading frame 11 (C9orf11), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412410 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 9 open reading frame 102 (C9orf102), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412592 | 100 ug | ORIGENE TECHNOLOGIES |
| Chromosome 8 open reading frame 79 (C8orf79), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426076 | 100 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 1 (UBE2D1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP721188 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 3 (UBE2D3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP721151 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2E 1 (UBC4/5 homolog, yeast) (UBE2E1), transcript variant 2 from ORIGENE TECHNOLOGIES | TP314934 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) (UBE2E2) from ORIGENE TECHNOLOGIES | TP304787 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2E 3 (UBE2E3), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760012 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, yeast) (UBE2G1) from ORIGENE TECHNOLOGIES | TP301159 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2E 3 (UBE2E3), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760647 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast) (UBE2G2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP720512 | 10 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast) (UBE2G2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP300407 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2G 2 (UBE2G2), transcript variant 2, full length from ORIGENE TECHNOLOGIES | TP760269 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast) (UBE2H), transcript variant 1 from ORIGENE TECHNOLOGIES | TP302516 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast) (UBE2H), transcript variant 2 from ORIGENE TECHNOLOGIES | TP313095 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast) (UBE2H), transcript variant 1 from ORIGENE TECHNOLOGIES | TP720162 | 10 ug | ORIGENE TECHNOLOGIES |